Hospira Cisplatin 50mg/50ml Concentrate for Infusion vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

公众评估报告 公众评估报告 (PAR)
29-11-2017

有效成分:

cisplatin, Quantity: 1 mg/mL

可用日期:

Hospira Australia Pty Ltd

INN(国际名称):

Cisplatin

药物剂型:

Injection, intravenous infusion

组成:

Excipient Ingredients: mannitol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid

给药途径:

Intravenous Infusion

每包单位数:

1 X 50mL

类:

Medicine Listed (Export Only)

处方类型:

(S1) This Schedule is intentionally blank

疗效迹象:

Cisplatin is indicated in metastatic, non seminomatous germ cell carcinoma, advanced stage and refractory ovarian carcinoma, advanced stages of refractory bladder carcinoma, advanced stages of refractory bladder carcinoma and squamous cell carcinoma of the head and neck. Cisplatin is indicated in combination with other antineoplastic agents for the treatment of metastatic testicular tumors.

產品總結:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

授权状态:

Licence status A

授权日期:

2009-03-10